Sort
30,917 grants matching “tumor microenvironment”
Mechanisms of Disseminated Tumor Cell Dormancy
$261,816Julio A Aguirre-Ghiso · Albert Einstein College Of Medicine · U54 · FY2014 · CA
Regulation of Genomic Instability in Early Breast Cancer
$261,802Thea D Tlsty · University Of California, San Francisco · R01 · FY2009 · CA
Tumor Induced Dysregulation of T Cell Immunity
$261,799James H Finke · Cleveland Clinic Lerner Com-Cwru · R01 · FY2007 · CA
P4 - Regulatory T-Cells in the Tumor Microenvironment of B-Cell Non-Hodgkin
$261,777Stephen M Ansell · University Of Iowa · P50 · FY2011 · CA
Mesenchymal Derived Growth Factors in Prostatic Cancer
$261,747David R Rowley · Baylor College Of Medicine · R01 · FY2011 · CA
Mesenchymal Derived Growth Factors in Prostatic Cancer
$261,747David R Rowley · Baylor College Of Medicine · R01 · FY2012 · CA
Gangliosides and the Biology of Human Neuroblastoma
$261,674Stephan Ladisch · Children'S Research Institute · R01 · FY2008 · CA
Gangliosides and the Biology of Human Neuroblastoma
$261,674Stephan Ladisch · Children'S Research Institute · R01 · FY2007 · CA
Tumor Induced Dysregulation of T Cell Immunity
$261,665James H Finke · Cleveland Clinic Lerner Com-Cwru · R01 · FY2009 · CA
Tumor Induced Dysregulation of T Cell Immunity
$261,665James H Finke · Cleveland Clinic Lerner Com-Cwru · R01 · FY2008 · CA
Microvesicle Dynamics in B-Cell Chronic Lymphocytic Leukemia Tumor Microenvironme
$261,640Asish Kumar Ghosh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2015 · CA
Prevention of MGUS Progression to MM by Modulating the Bone Marrow Microenvironment
$261,630Fenghuang Zhan · Baylor College Of Medicine · U54 · FY2024 · CA
Bone and Soft Tissue Tumor Etiology: Role and Function of TRE17/USP6
$261,619Margaret Mary Chou · Children'S Hosp Of Philadelphia · R01 · FY2015 · CA
Core 2: Theory Core - Multiscale models for mechano-chemical phenomena
$261,535Andrea Liu · University Of Pennsylvania · U54 · FY2015 · CA
Determining Tumor Metabolism and Biochemical Mechanism of beta-glucan Action in
$261,521Jun Yan · University Of Kentucky · P01 · FY2014 · CA
Bipolar Androgen Therapy for Progressive Castrate Resistant Prostate Cancer
$261,450Samuel R Denmeade · Johns Hopkins University · R01 · FY2015 · CA
Hematopoietic Stem Cell-Derived Carcinoma Associated Fibroblasts in Tumor
$261,450Amanda C. Larue · Medical University Of South Carolina · R01 · FY2012 · CA
Bipolar Androgen Therapy for Progressive Castrate Resistant Prostate Cancer
$261,450Samuel R Denmeade · Johns Hopkins University · R01 · FY2014 · CA
Bipolar Androgen Therapy for Progressive Castrate Resistant Prostate Cancer
$261,450Samuel R Denmeade · Johns Hopkins University · R01 · FY2016 · CA
Hematopoietic Stem Cell-Derived Carcinoma Associated Fibroblasts in Tumor
$261,450Amanda C. Larue · Medical University Of South Carolina · R01 · FY2011 · CA
Hematopoietic Stem Cell-Derived Carcinoma Associated Fibroblasts in Tumor
$261,450Amanda C. Larue · Medical University Of South Carolina · R01 · FY2015 · CA
Complex ganglioside function in neuroblastoma
$261,450Children'S Research Institute · R01 · FY2005 · CA
Bipolar Androgen Therapy for Progressive Castrate Resistant Prostate Cancer
$261,450Samuel R Denmeade · Johns Hopkins University · R01 · FY2018 · CA
Bipolar Androgen Therapy for Progressive Castrate Resistant Prostate Cancer
$261,450Samuel R Denmeade · Johns Hopkins University · R01 · FY2017 · CA
Multi-omic Predictive Markers for Ovarian Cancer Therapy Response and Outcomes
$261,420Francesmary Modugno · Magee-Women'S Res Inst And Foundation · R21 · FY2022 · CA